Merrimack

Merrimack

Merrimack

We are committed to the fight against cancer. We seek to understand the complexity of the disease and engineer life-saving solutions through our science.
Founded
2000
Raised
$77M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$77,000,000
Private equity - 2011
Credit Suisse Jennison Associates Crocker Ventures +3
Undisclosed amount
Undisclosed funding - 2006
University Venture Fund
Team Size
200+
Employees
Xconomy

Merrimack Hits Reset Button, Sells Cancer Drugs to Ipsen For $575M

Health Strategy Earnings
Xconomy

Still Stuck Below IPO Price, Merrimack Restructures, CEO Resigns

Health Earnings
The Motley Fool

Here's Why Merrimack Pharmaceuticals' Stock Has Been Getting Crushed in 2016

The Motley Fool

Why Merrimack Pharmaceuticals' Stock Is Sliding Today